A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: A motor behavioural analysis

Neuroscience

Volumn 115, Issue 2, 2002, Pages 533-546

  Ghorayeb, I ^a   Fernagut, P O ^a   Hervier, L ^a   Labattu, B ^a   Bioulac, B ^a   Tison, F ^a  

^a CNRS   (France)

Author keywords

Animal model; Multiple system atrophy; Paw reaching; Rotations; Stepping test; Thigmotactic scanning

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; APOMORPHINE; OXIDOPAMINE; QUINOLINIC ACID; TOXIN;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BRAIN ASYMMETRY; BRAIN INJURY; BRAIN SCINTISCANNING; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INJECTION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; STRIATE CORTEX; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; THALAMUS; THALAMUS PARAFASCICULAR NUCLEUS;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FORELIMB; HERBICIDES; INTRALAMINAR THALAMIC NUCLEI; MALE; MOTOR ACTIVITY; MOTOR CORTEX; MPTP POISONING; MULTIPLE SYSTEM ATROPHY; NERVE DEGENERATION; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 0037146648     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00401-3     Document Type: Article

References (74)

1. Ahlenius S., Anden N.E., Grabowska-Anden M. Apomorphine-induced ipsilateral turning in rats with unilateral lesions of the parafascicular nucleus. Exp. Brain Res. 47:1982;270-276.
2. +): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation. Eur. J. Pharmacol. 131:1986;199-209.
3. Barker R., Dunnett S.B. Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat. Exp. Brain Res. 101:1994;365-374.
4. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
5. Blum D., Torch S., Lambeng N., Nissou M., Benabid A., Sadoul R., Verna J. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65:2001;135-172.
6. Bradbury A.J., Costall B., Domeney A.M., Jenner P., Kelly M.E., Marsden C.D., Naylor R.J. 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature. 319:1986;56-57.
7. Brouillet E., Conde F., Beal M.F., Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol. 59:1999;427-468.
8. Buisson A., Plateau V., Plotkine M., Boulu R.G. Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid. Neurosci. Lett. 131:1991;257-259.
9. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
10. Butcher, L.L., 1983. Acetylcholinesterase histochemistry. In: Björklund, A., Hökfelt, T. (Eds.), Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam, pp. 1-49.
11. +) on mitochondrial membrane potential in cerebellar neurons: interaction with the NMDA receptor. J. Neural. Transm. 104:1997;569-577.
12. Chang J.W., Wachtel S.R., Young D., Kang U.J. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesion. Neuroscience. 88:1999;617-628.
13. Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Pert A., Kopin I.J. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur. J. Pharmacol. 100:1984;189-194.
14. Churchyard A., Donnan G.A., Hughes A., Howells D.W., Woodhouse D., Wong J.Y., Kalnins R.M., Mendelsohn F.A., Paxinos G. Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors. Ann. Neurol. 34:1993;219-226.
15. Cousins M.S., Salamone J.D. Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization. Brain Res. 732:1996;186-194.
16. Cousins M.S., Salamone J.D. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience. 70:1996;849-859.
17. Dunnett S.B., Isacson O., Sirinathsinghji D.J.S., Clarke D.J., Björklund A. Striatal grafts in rats with unilateral neostriatal lesions - III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience. 24:1988;813-820.
18. Dunnett S.B., Iversen S.D. Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum. Brain Res. 248:1982;121-127.
19. Dunnett S.B., Iversen S.D. Spontaneous and drug-induced rotation following localized 6-hydroxydopamine and kaïnic acid-induced lesions of the neostriatum. Neuropharmacology. 21:1982;899-908.
20. +-lesioned rats: a microdialysis study in vivo. Neurochem. Res. 23:1998;1217-1223.
21. + produces progressive neuronal degeneration which is mediated by oxidative stress. Exp. Neurol. 144:1997;193-198.
22. Fearnley J.M., Lees A.J. Striatonigral degeneration. A clinicopathological study. Brain. 113:1990;1823-1842.
23. Fornaguera J., Carey R.J., Huston J.P., Schwarting R.K.W. Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion. Brain Res. 664:1994;178-188.
24. Fornaguera J., Schwarting R.K.W., Boix F., Huston J.P. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model. Synapse. 13:1993;179-185.
25. Fricker R.A., Annett L.E., Torres E.M., Dunnett S.B. The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation. Brain Res. Bull. 41:1996;409-416.
26. Friehs G.M., Parker R.G., He L.S., Haines S.J., Turner D.A., Ebner T.J. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of Parkinsonism. J. Neural. Transplant. Plast. 2:1991;141-156.
27. Frim D.M., Uhler T.A., Galpern W.R., Beal M.F., Breakefield X.O., Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA. 91:1994;5104-5108.
28. Ghorayeb I., Puschban Z., Fernagut P.O., Scherfler C., Rouland R., Wenning G.K., Tison F. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. Exp. Neurol. 167:2001;133-147.
29. Gonzales-Lima, F., Cada, M., 1998. Quantitative histochemistry of cytochrome oxidase activity. Theory, methods and regional brain vulnerability. In: Gonzales-Lima, F. (Ed.), Cytochrome Oxidase in Neuronal Metabolism and Alzheimer's Disease. Plenum Press, New York, pp. 55-90.
30. Gonzalez-Polo R.A., Mora A., Clemente N., Sabio G., Centeno F., Soler G., Fuentes J.M. Mechanisms of MPP(+) incorporation into cerebellar granule cells. Brain Res. Bull. 56:2001;119-123.
31. Goto S., Hirano A., Matsumoto S. Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology. 40:1990;1051-1056.
32. Goto S., Matsumoto S., Ushio Y., Hirano A. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause Parkinsonism in striatonigral degeneration. Neurology. 47:1996;1032-1036.
33. +) to rats. Neurosci. Lett. 59:1985;135-140.
34. Hudson J.L., van Horne C.G., Strömberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626:1993;167-174.
35. Kafetzopoulos E., Vlaha V., Konitsiotis S. Different patterns of rotational behavior in rats after dorsal or ventral striatal lesions with ibotenic acid. Pharmacol. Biochem. Behav. 29:1988;403-406.
36. Kaji R., Murase N. Sensory function of basal ganglia. Mov. Disord. 16:2001;593-594.
37. Kirik D., Rosenblad C., Björklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152:1998;259-277.
38. Kume A., Takahashi A., Hashizume Y. Neuronal cell loss of the striatonigral system in multiple system atrophy. J. Neurol. Sci. 117:1993;33-40.
39. Lantos P.L. The definition of multiple system atrophy: a review of recent developments. J. Neuropath. Exp. Neurol. 57:1998;1099-1111.
40. Lee C.S., Sauer H., Björklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience. 72:1996;641-653.
41. Marini A.M., Schwartz J.P., Kopin I.J. The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9:1989;3665-3672.
42. McGeorge A.J., Faul R.L. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
43. +. J. Neurochem. 73:1999;750-757.
44. Mitchell I.J., Cooper A.J., Griffiths M.R. The selective vulnerability of striatopallidal neurons. Prog. Neurobiol. 59:1999;691-719.
45. Montoya C.P., Campbell H.L., Pemberton K.D., Dunnett S.B. The 'staircase test': a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods. 36:1991;219-228.
46. Nakao N., Brundin P. Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience. 76:1997;749-761.
47. Norman A.B., Norgren R.B., Wyatt L.M., Hildebrand J.P., Sanberg P.R. The direction of apomorphine-induced rotation behavior is dependent on the location of excitotoxin lesions in the rat basal ganglia. Brain Res. 569:1992;169-172.
48. Olsson M., Nikkhah G., Bentlage C., Björklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:1995;3863-3875.
49. Paxinos, G., Watson, C., 1982. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
50. Pisa M. Motor functions of the striatum in the rat: critical role of the lateral region in tongue and forelimb reaching. Neuroscience. 24:1988;453-463.
51. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
52. Roberts R.C., Ahn A., Swartz K.J., Beal M.F., DiFiglia M. Intrastriatal injection of quinolinic acid or kaïnic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp. Neurol. 124:1993;274-282.
53. Salin P., Nieoullon A. The contralateral cortex contributes to the effects of hemidecortication on neuropeptide Y immunoreactivity in the rat striatum. Neurosci. Lett. 220:1996;179-182.
54. Sanberg P.R., Calderon S.F., Giordano M., Tew J., Norman A. The quinolinic acid model of Huntington's disease: locomotor abnormalities. Exp. Neurol. 105:1989;45-53.
55. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience. 59:1994;401-415.
56. Scherfler C., Puschban Z., Ghorayeb I., Goebel G.P., Tison F., Jellinger K., Poewe W., Wenning G.K. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience. 99:2000;43-54.
57. Schwarting R.K., Steiner H., Huston J.P. Asymmetries in thigmotactic scanning: evidence for a role of dopaminergic mechanisms. Psychopharmacology (Berl.). 103:1991;19-27.
58. Schwarting R.K.W., Goldenberg R., Steiner H., Fornaguera J., Huston J.P. A video image analyzing system for open-field behavior in the rat focusing on behavioral asymmetries. J. Neurosci. Methods. 49:1993;199-210.
59. Schwarting R.K.W., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50:1996;275-331.
60. Shinoto H., Inoue O., Hirayama K., Aotsuka A., Asahina A., Suhara T., Yamazaki T., Tateno Y. Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J. Neurol. Neurosurg. Psychiatry. 56:1993;467-472.
61. +) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol. Aging. 14:1993;295-301.
62. Stefanis L., Burke R.E. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution and morphology of cell death. Neuroscience. 74:1996;997-1008.
63. Storey E., Hyman B.T., Jenkins B., Brouillet E., Miller J.M., Rosen B.R., Beal M.F. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 58:1992;1975-1978.
64. Sundstrom E., Mo L.L. Effects of 1-methyl-4-phenylpyridinium on radioligand binding to the NMDA receptor complex. Res. Commun. Mol. Pathol. Pharmacol. 88:1995;131-136.
65. Tison F., Wenning G.K., Daniel S.E., Quinn N.P. The pathophysiology of Parkinsonism in multiple system atrophy. Eur. J. Neurol. 2:1995;435-444.
66. Venero J.L., Romero-Ramos M., Revuelta M., Machado A., Cano J. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal pathway. Brain Res. 672:1995;153-158.
67. Volpe B.T., Wildmann J., Altar C.A. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience. 83:1998;741-748.
68. Waldner R., Puschban Z., Scherfler C., Seppi K., Jellinger K., Poewe W., Wenning G.K. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Neuroscience. 102:2001;581-592.
69. Watts C., Dunnett S.B. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: implications for timing of surgical intervention. J. Neurosurg. 89:1998;267-274.
70. Webster K.E. Cortico-striate interrelations in the albino rat. J. Anat. 95:1961;532-544.
71. Wenning G.K., Granata R., Laboyrie P.M., Quinn N.P., Jenner P., Marsden C.D. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov. Disord. 11:1996;522-532.
72. Wenning G.K., Tison F., Ben-Shlomo Y., Daniel S.E., Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov. Disord. 12:1997;133-147.
73. Wenning G.K., Tison F., Scherfler C., Puschban Z., Waldner R., Granata R., Ghorayeb I., Poewe W. Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis and preliminary experimental evidence. Cell Transpl. 9:2000;279-288.
74. Whishaw I.Q., O'Connor W.T., Dunnett S.B. The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat. Brain. 109:1986;805-843.